Cytokine response in patients with chronic infections caused by Staphylococcus aureus strains and diversification of their Agr system classes

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 31, Issue 10, 2012, Pages 2809-2815

  Szkaradkiewicz, A ^a   Karpinski T M ^a   Zeidler, A ^a   Szkaradkiewicz, A K ^a   Masiuk, H ^b   Giedrys Kalemba, S ^b  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 1BETA; INTERLEUKIN 4; TUMOR NECROSIS FACTOR ALPHA;

ADULT; AGR GENE; ARTICLE; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIUM CULTURE; CHRONIC SUPPURATIVE DERMATITIS; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RESPONSE; FEMALE; GENETIC VARIABILITY; HUMAN; MACROPHAGE; MAJOR CLINICAL STUDY; MONOCYTE; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; STAPHYLOCOCCAL SKIN INFECTION; STAPHYLOCOCCUS AUREUS; SUPPURATION; TH1 CELL; TH17 CELL; THROAT CULTURE;

EID: 84869104283     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-012-1633-7     Document Type: Article

References (38)

1. Espersen F, Hedström SA (1984) Recurrent staphylococcal furunculosis: antibody response against Staphylococcus aureus. Scand J Infect Dis 16:413-414
2. Proctor RA, Balwit JM, Vesga O (1994) Variant subpopulations of Staphylococcus aureus as cause of persistent and recurrent infections. Infect Agents Dis 3:302-312
3. Lowy FD (1998) Staphylococcus aureus infections. N Engl J Med 339:520-532
4. Clement S, Vaudaux P, Francois P et al (2005) Evidence of an intracellular reservoir in the nasal mucosa of patients with recurrent Staphylococcus aureus rhinosinusitis. J Infect Dis 192:1023-1028
5. Medzhitov R (2007) Recognition of microorganisms and activation of the immune response. Nature 449:819-826
6. Lindsay JA, Holden MT (2004) Staphylococcus aureus: superbug, super genome? Trends Microbiol 12:378-385
7. Foster TJ (2005) Immune evasion by staphylococci. Nat Rev Microbiol 3:948-958
8. Ji G, Beavis R, Novick RP (1997) Bacterial interference caused by autoinducing peptide variants. Science 276:2027-2030
9. Novick RP (2003) Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 48:1429-1449
10. Jarraud S, Mougel C, Thioulouse J et al (2002) Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 70:631-641
11. Shopsin B, Mathema B, Alcabes P et al (2003) Prevalence of agr specificity groups among Staphylococcus aureus strains colonizing children and their guardians. J Clin Microbiol 41:456-459
12. Campoccia D, Baldassarri L, Pirini V et al (2008) Molecular epidemiology of Staphylococcus aureus from implant orthopaedic infections: ribotypes, agr polymorphism, leukocidal toxins and antibiotic resistance. Biomaterials 29:4108-4116
13. Mosmann TR, Sad S (1996) The expanding universe of T-cell subsets: Th1, Th2 and more. Immunol Today 17:138-146
14. Moser M, Murphy KM (2000) Dendritic cell regulation of TH1-TH2 development. Nat Immunol 1:199-205
15. Mege J-L, Meghari S, Honstettre A et al (2006) The two faces of interleukin 10 in human infectious diseases. Lancet Infect Dis 6:557-569
16. Reiner SL (2007) Development in motion: helper T cells at work. Cell 129:33-36
17. Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87-113
18. Medzhitov R, Janeway CA Jr (1997) Innate immunity: impact on the adaptive immune response. Curr Opin Immunol 9:4-9
19. Breuer K, Wittmann M, Kempe K et al (2005) Alpha-Toxin is produced by skin colonizing Staphylococcus aureus and induces a T helper type 1 response in atopic dermatitis. Clin Exp Allergy 35:1088-1095
20. Niebuhr M, Gathmann M, Scharonow H et al (2011) Staphylococcal alpha-Toxin is a strong inducer of interleukin-17 in humans. Infect Immun 79:1615-1622
21. Frodermann V, Chau TA, Sayedyahossein S et al (2011) A modulatory interleukin-10 response to staphylococcal peptidoglycan prevents Th1/Th17 adaptive immunity to Staphylococcus aureus. J Infect Dis 204:253-262
22. Koga C, Kabashima K, Shiraishi N et al (2008) Possible pathogenic role of Th17 cells for atopic dermatitis. J Invest Dermatol 128:2625-2630
23. Lowes MA, Kikuchi T, Fuentes-Duculan J et al (2008) Psoriasis vulgaris lesions contain discrete populations of Th1 and Th17 T cells. J Invest Dermatol 128:1207-1211
24. Acosta-Rodriguez EV, Rivino L, Geginat J et al (2007) Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat Immunol 8:639-646
25. Lexberg MH, Taubner A, Albrecht I et al (2010) IFN-? and IL-12 synergize to convert in vivo generated Th17 into Th1/Th17 cells. Eur J Immunol 40:3017-3027
26. Kagami S, Rizzo HL, Lee JJ et al (2010) Circulating Th17, Th22, and Th1 cells are increased in psoriasis. J Invest Dermatol 130:1373-1383
27. Boniface K, Blumenschein WM, Brovont-Porth K et al (2010) Human Th17 cells comprise heterogeneous subsets including IFN-?-producing cells with distinct properties from the Th1 lineage. J Immunol 185:679-687
28. Cho JS, Pietras EM, Garcia NC et al (2010) IL-17 is essential for host defense against cutaneous Staphylococcus aureus infection in mice. J Clin Invest 120:1762-1773
29. Krishnaswamy G, Kelley J, Yerra L et al (1999) Human endothelium as a source of multifunctional cytokines: molecular regulation and possible role in human disease. J Interferon Cytokine Res 19:91-104
30. Minegishi Y, Saito M, Nagasawa M et al (2009) Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome. J Exp Med 206:1291-1301
31. Gagnaire J, Dauwalder O, Boisset S et al (2012) Lack of Staphylococcus aureus delta-Toxin production as detected by whole cell MALDI-TOF MS in routine practice is associated with chronicity of infection. Clin Microbiol Infect 3 (Suppl):694, Abstract P2355
32. Zielinski CE, Mele F, Aschenbrenner D et al (2012) Pathogen-induced human Th17 cells produce IFN-? or IL-10 and are regulated by IL-1ß. Nature 484:514-518. doi:10.1038/nature10957
33. Garbacz K, Piechowicz L, Wisniewska K et al (2009) Diversification of agr locus among Staphylococcus aureus isolated fromcarriers and from hospital patients with infection syndromes. Med Dosw Mikrobiol 61:5-9
34. Collery MM, Smyth DS, Twohig JM et al (2008) Molecular typing of nasal carriage isolates of Staphylococcus aureus from an Irish university student population based on toxin gene PCR, agr locus types and multiple locus, variable number tandem repeat analysis. J Med Microbiol 57:348-358
35. Jarraud S, Lyon GJ, Figueiredo AM et al (2000) Exfoliatinproducing strains define a fourth agr specificity group in Staphylococcus aureus. J Bacteriol 182:6517-6522
36. Ladhani S, Joannou CL, Lochrie DP et al (1999) Clinical, microbial, and biochemical aspects of the exfoliative toxins causing staphylococcal scalded-skin syndrome. Clin Microbiol Rev 12:224-242
37. Müller-Alouf H, Carnoy C, Simonet M et al (2001) Superantigen bacterial toxins: state of the art. Toxicon 39:1691-1701
38. Mele T, Madrenas J (2010) TLR2 signalling: at the crossroads of commensalism, invasive infections and toxic shock syndrome by Staphylococcus aureus. Int J Biochem Cell Biol 42:1066-1071